D. Eton

发表

Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales.

D. Cella, J. Lai, D. Eton, 2002, Journal of pain and symptom management.

Guideline for the management of clinically localized prostate cancer: 2007 update.

A. D'Amico, C. Tangen, D. Eton, 2007, The Journal of urology.

The measurement of imagery vividness: A test of the reliability and validity of the Vividness of Visual Imagery Questionnaire and the Vividness of Movement Imagery Questionnaire.

D. Eton, D. Munz, F. Gilner, 1998 .

Patient engagement in research: a systematic review

J. Sloan, D. Eton, V. Montori, 2014, BMC Health Services Research.

Factors associated with decisions to step down asthma medications.

D. Eton, N. Shah, J. Ziegenfuss, 2013, The journal of allergy and clinical immunology. In practice.

Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness

Alison Richardson, Katie Gallacher, Victor M Montori, 2014, BMC Health Services Research.

Future trends in patient-reported outcomes assessment for patients with advanced-stage lung cancer receiving targeted therapy.

D. Cella, D. Eton, K. Yost, 2006, Clinical lung cancer.

Impact of childhood psoriasis on parents of affected children

D. Eton, M. Tollefson, D. Finnie, 2017, Journal of the American Academy of Dermatology.

Systematic review of patient-reported measures of treatment burden in stroke

F. Mair, D. Eton, P. Erwin, 2019, BMJ Open.

Validating the Patient Experience with Treatment and Self-Management (PETS), a patient-reported measure of treatment burden, in people with diabetes

Roger. T. Anderson, D. Eton, M. Linzer, 2017, Patient related outcome measures.

A Brief Patient-Reported Outcomes Quality of Life (PROQOL) Instrument to Improve Patient Care

C. Chute, J. Sloan, D. Eton, 2013, PLoS medicine.

Relationship between symptom change, objective tumor measurements, and performance status during chemotherapy for advanced lung cancer.

B. Parasuraman, D. Cella, D. Eton, 2008, Clinical lung cancer.

An innovative symptom monitoring tool for people with advanced lung cancer: a pilot demonstration.

D. Cella, D. Eton, S. Yount, 2007, The journal of supportive oncology.

The development and initial validation of the PROMIS®+HF‐27 and PROMIS+HF‐10 profiles

C. Yancy, S. Kimmel, A. Kho, 2022, ESC heart failure.

Factors Influencing Cancer Risk Perception in High Risk Populations: A Systematic Review

Pamela S. Sinicrope, B. Costello, D. Eton, 2011, Hereditary cancer in clinical practice.

Effects of patient-reported outcome assessment order

E. Basch, J. Sloan, P. Novotny, 2022, Clinical trials.

Minimally important differences were estimated for six PROMIS-Cancer scales in advanced-stage cancer patients

D. Cella, D. Eton, S. Garcia, 2011 .

Patient experience after kidney transplant: a conceptual framework of treatment burden

M. Stegall, D. Eton, A. Cheville, 2019, Journal of Patient-Reported Outcomes.

Development and Validation of a Kidney-Transplant Specific Measure of Treatment Burden

D. Eton, K. Yost, T. Petterson, 2022, BMC Nephrology.

A brief symptom index for advanced renal cell carcinoma

R. Motzer, J. Bacik, D. Cella, 2006, Health and quality of life outcomes.

Validation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI)

D. Cella, D. Eton, S. Yount, 2005, Breast Cancer Research and Treatment.

A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale.

D. Neuberg, G. Sledge, D. Cella, 2004, Journal of clinical epidemiology.

What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592.

D. Cella, D. Fairclough, D. Eton, 2002, Journal of clinical epidemiology.

A preliminary analysis of medical futility decisionmaking: law and professional attitudes.

D. Eton, R. Wiener, J. A. Goldner, 1998, Behavioral sciences & the law.

Do erythropoietic-stimulating agents relieve fatigue? A review of reviews.

D. Cella, D. Eton, 2011, Cancer treatment and research.

Why we need response shift: an appeal to functionalism

D. Eton, 2010, Quality of Life Research.

Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden

C. May, J. Lai, D. Eton, 2017, Quality of Life Research.

Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions

P. Ravaud, D. Eton, V. Montori, 2012, BMC Medicine.

Healthcare provider relational quality is associated with better self-management and less treatment burden in people with multiple chronic conditions

Sara Poplau, Mark Linzer, Kathleen J Yost, 2017, Patient preference and adherence.

Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.

Anthony V D'Amico, Javier Hernandez, Arthur L Burnett, 2007, The Journal of urology.

Estimating clinically meaningful changes for the Functional Assessment of Cancer Therapy--Prostate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancer.

J. Nelson, D. Cella, D. Eton, 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Clinically meaningful changes in health-related quality of life in patients diagnosed with hepatobiliary carcinoma.

D. Cella, D. Eton, B. Carr, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592.

D. Cella, D. Fairclough, D. Eton, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prostate cancer and health‐related quality of life: a review of the literature

D. Eton, S. Lepore, 2002, Psycho-oncology.

Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative study

C. May, D. Eton, V. Montori, 2012, Patient related outcome measures.

Quality of life in lung cancer: the validity and cross-cultural applicability of the Functional Assessment Of Cancer Therapy-Lung scale.

J. Beaumont, D. Cella, D. Eton, 2005, Hematology/oncology clinics of North America.

Psychological distress in spouses of men treated for early‐stage prostate carcinoma

V. Helgeson, D. Eton, S. Lepore, 2005, Cancer.

Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches.

D. Cella, D. Eton, D. West, 2005, Journal of clinical epidemiology.

Combining Distribution- and Anchor-Based Approaches to Determine Minimally Important Differences

D. Eton, K. Yost, 2005, Evaluation & the health professions.

Meta-analysis provides evidence-based effect sizes for a cancer-specific quality-of-life questionnaire, the FACT-G.

D. Osoba, M. Stockler, D. Cella, 2010, Journal of clinical epidemiology.

Responsiveness of 8 Patient‐Reported Outcomes Measurement Information System (PROMIS) measures in a large, community‐based cancer study cohort

R. Hays, D. Cella, E. Hahn, 2017, Cancer.

Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients.

D. Cella, D. Eton, S. Garcia, 2011, Journal of clinical epidemiology.

Patient-reported outcomes in studies of complementary and alternative medicine: problems, solutions, and future directions.

J. Sloan, D. Eton, B. Bauer, 2011, Explore.

D. Osoba, M. Stockler, D. Cella, 2022 .

Developing a self-report outcome measure for complementary and alternative medicine.

D. Cella, D. Eton, J. Astin, 2005, Explore.

Is patient assessment of asthma care delivery associated with publicly reported performance measures?

D. Eton, N. Shah, J. Ziegenfuss, 2013, The Journal of asthma : official journal of the Association for the Care of Asthma.

Comparing Measures to Assess Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction.

D. Eton, S. Dunlay, S. McNulty, 2018, JACC. Heart failure.

A brief assessment of physical functioning for prostate cancer patients

D. Cella, J. Lai, D. Eton, 2010, Patient related outcome measures.

Harmonizing and consolidating the measurement of patient-reported information at health care institutions: a position statement of the Mayo Clinic

Victor M Montori, Douglas L Wood, Jeff A Sloan, 2014, Patient related outcome measures.

Validation of the functional assessment of cancer therapy--lung symptom index-12 (FLSI-12).

D. Cella, D. Eton, S. Yount, 2007, Lung cancer.

Switching breast cancer patients with progressive bone metastases to third-generation bisphosphonates: measuring impact using the Functional Assessment of Cancer Therapy-Bone Pain.

D. Cella, D. Eton, G. Dranitsaris, 2009, Journal of pain and symptom management.

A systematic review of patient-reported measures of burden of treatment in three chronic diseases

D. Eton, V. Montori, P. Erwin, 2013, Patient related outcome measures.

Qualitative systematic reviews of treatment burden in stroke, heart failure and diabetes - Methodological challenges and solutions

F. Mair, C. May, D. Eton, 2013, BMC Medical Research Methodology.

Factors that lessen the burden of treatment in complex patients with chronic conditions: a qualitative study

D. Eton, V. Montori, M. Linzer, 2014, Patient preference and adherence.

Impact of comorbidities and treatment burden on general well-being among women’s cancer survivors

F. Camacho, D. Eton, C. Brenin, 2021, Journal of Patient-Reported Outcomes.

Score equivalence of paper-, tablet-, and interactive voice response system-based versions of PROMIS, PRO-CTCAE, and numerical rating scales among cancer patients

P. Novotny, D. Eton, J. Sloan, 2021, Journal of Patient-Reported Outcomes.

Quality of life after early mitral valve repair using conventional and robotic approaches.

D. Eton, H. Schaff, R. Suri, 2012, The Annals of thoracic surgery.

Reserve-building activities attenuate treatment burden in chronic illness: The mediating role of appraisal and social support

C. Schwartz, B. Rapkin, D. Eton, 2018, Health psychology open.

Uncovering Treatment Burden as a Key Concept for Stroke Care: A Systematic Review of Qualitative Research

Sara Macdonald, Peter Langhorne, Victor M. Montori, 2013, PLoS medicine.

Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions.

V. Helgeson, D. Eton, R. Schulz, 2003, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Pilot validation of a self-report outcome measure of complementary and alternative medicine.

D. Eton, L. Temple, K. Koffler, 2007, Explore.

Constructing a conceptual framework of patient-reported outcomes for metastatic hormone-refractory prostate cancer.

J. Beaumont, D. Cella, D. Eton, 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Erectile function outcome reporting after clinically localized prostate cancer treatment.

Anthony V D'Amico, Javier Hernandez, S Larry Goldenberg, 2007, The Journal of urology.

Risk factors for poor health-related quality of life in cancer survivors with multiple chronic conditions: exploring the role of treatment burden as a mediator

D. Eton, J. S. St. Sauver, K. Ruddy, 2019, Patient related outcome measures.

Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance.

B. Reeve, D. Cella, N. Aaronson, 2014, Urologic oncology.

Longitudinal trajectories of treatment burden: A prospective survey study of adults living with multiple chronic conditions in the midwestern United States

D. Eton, J. S. St. Sauver, M. Linzer, 2022, Journal of multimorbidity and comorbidity.

Functional Outcomes and Health-Related Quality of Life Before and After Primary Total Knee Replacement for Patients From Diverse Geographic Regions.

D. Eton, M. A. Nyman, Minji K. Lee, 2021, The Journal of arthroplasty.

Identifying meaningful change on PROMIS short forms in cancer patients: a comparison of item response theory and classic test theory frameworks

J. Sloan, P. Novotny, D. Cella, 2022, Quality of Life Research.

Early quality of life in patients with localized prostate carcinoma

V. Helgeson, D. Eton, S. Lepore, 2001, Cancer.

Validation of the functional assessment of cancer therapy esophageal cancer subscale

D. Cella, D. Eton, G. Darling, 2006, Cancer.

Confirmatory Factor Analyses and Differential Item Functioning of the Patient Experience with Treatment and Self-Management (PETS vs. 2.0): A Measure of Treatment Burden

D. Eton, J. S. St. Sauver, M. Linzer, 2021, Patient related outcome measures.

Deriving and validating a brief measure of treatment burden to assess person-centered healthcare quality in primary care: a multi-method study

C. Vanderboom, D. Eton, M. Linzer, 2020, BMC Family Practice.

Known-groups validity and responsiveness to change of the Patient Experience with Treatment and Self-management (PETS vs. 2.0): a patient-reported measure of treatment burden

D. Eton, J. S. St. Sauver, Minji K. Lee, 2020, Quality of Life Research.

PROM_A_282728 249..263

D. Eton, M. Linzer, Minji K. Lee, 2020 .

Spouse Social Control Efforts: Relations to Health Behavior and Well-Being among Men with Prostate Cancer

V. Helgeson, D. Eton, S. Lepore, 2004 .

Data Pooling and Analysis to Build a Preliminary Item Bank

B. Reeve, D. Cella, J. Lai, 2005, Evaluation & the Health Professions.

Coping with colorectal cancer: a qualitative exploration with patients and their family members.

D. Eton, Carmen Radecki Breitkopf, David T Eton, 2014, Family practice.

Moderators of the benefits of psychoeducational interventions for men with prostate cancer.

V. Helgeson, D. Eton, S. Lepore, 2006, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions

Victor M Montori, Sara Poplau, Mark Linzer, 2015, Patient related outcome measures.

The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma

J. Cerhan, T. Habermann, T. Shanafelt, 2013, Leukemia & lymphoma.

Response shifts in prostate cancer patients: An evaluation of suppressor and buffer models.

D. Eton, S. Lepore, 2000 .

Treatment of taste alterations in chemotherapy patients using the "miracle fruit": Preliminary analysis of a pilot study.

J. Beaumont, D. Eton, H. Soares, 2010 .

Lessons Learned: Recruiting Research Participants from an Underrepresented Patient Population at a Safety Net Hospital

D. Eton, M. Linzer, Miamoua Vang, 2022, Journal of General Internal Medicine.

Treatment Burden in People with Hypertension is Correlated with Patient Experience with Self-Management

D. Eton, M. Linzer, Elizabeth A Rogers, 2021, The Journal of the American Board of Family Medicine.

Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions

C. May, D. Eton, V. Montori, 2015, Patient related outcome measures.

Protocol for the development and validation of a patient reported measure (PRM) of treatment burden in stroke

D. Eton, T. Quinn, H. Mcleod, 2023, Health Open Research.

Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions

D. Eton, V. Montori, M. Linzer, 2015 .

Meta-analysis provides evidence-based interpretation guidelines for the clinical significance of mean differences for the FACT-G, a cancer-specific quality of life questionnaire

D. Osoba, M. Stockler, D. Cella, 2010, Patient Related Outcome Measures.

Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness

F. Mair, D. Eton, V. Montori, 2014, BMC Health Services Research.

Adaptation and content validation of a patient-reported measure of treatment burden for use in stroke survivors: the patient experience with treatment and self-management in stroke (PETS-stroke) measure.

D. Eton, Karen Wood, L. Kidd, 2023, Disability and rehabilitation.

Understanding the treatment burden of people with chronic conditions in Kenya: A cross-sectional analysis using the Patient Experience with Treatment and Self-Management (PETS) questionnaire

D. Eton, P. Perel, A. Murphy, 2023, PLOS Global Public Health.

Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden

C. May, J. Lai, D. Eton, 2017, Quality of Life Research.

Reducing the Burden of Treatment: Addressing How Our Patients Feel About What We Ask of Them: A "Less Is More" Perspective.

D. Eton, M. Linzer, Elizabeth A Rogers, 2022, Mayo Clinic proceedings.

J. Sloan, D. Eton, V. Montori, 2022 .

Treatment burden for people experiencing homelessness with a recent non-fatal overdose: a questionnaire study

D. Eton, Andrea E. Williamson, R. Lowrie, 2023, The British journal of general practice : the journal of the Royal College of General Practitioners.